Transcriptomic characterization of plasma exosomes
- Response deadline
- Aug 31, 2026 Closed
- Date posted
- Aug 20, 2026
- Source
- Open notice
Description
The primary purpose of this acquisition is to obtain consumables and reagents essential for processing 650 plasma exosomal RNA samples for next generation sequencing. The Center for Research on Genomics and Global employs various molecular biology techniques to investigate the pathophysiology of cardiometabolic diseases and associated traits across diverse populations. This project aims to characterize the gene expression profile of plasma exosomes, which are implicated in several diseases. Plasma, a biological fluid collected via minimally invasive methods, serves as an indicator of health and disease status. Molecular analysis of plasma may further elucidate disease mechanisms and facilitate the discovery of novel biomarkers. Consumables and reagents supplied by New England Biolabs (NEB) are utilized in generating all necessary products for sequencing on the Illumina platform, the system currently available to NHGRI investigators through the core laboratory supporting this ongoing project.
Documents (2)
- SOW_ NEB_PCA_NHGRI_09000.docx.docx24 KBNot yet available
- PCA-NHGRI-09000 NOI.docx.docx20 KBNot yet available
Contacts
Similar contracts
- Intent to Sole Source - Fertility Preservation Lab ServicesMarylandDue Oct 24, 2026
- Intent to Sole Source - IntelliBlate Ximitry ProbeMarylandDue Oct 16, 2026
- Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical CenterMarylandDue Oct 23, 2026
- Administrative Systems Technology Officer Mission Support Services (ASTO MSS) for NIH Integrated Data Platform (IDP) and Deputy Director for Management - Justification PostingMaryland
- Ultra Highspeed Megapixel CMOS Imaging CameraMarylandDue Sep 23, 2026
- Intent to Sole Source - Cross Platform for Pediatric Patients at the Clinical CenterMarylandDue Sep 27, 2026